Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

BARRECA, Marilia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.930
EU - Europa 1.598
AS - Asia 1.061
Continente sconosciuto - Info sul continente non disponibili 320
SA - Sud America 278
AF - Africa 39
OC - Oceania 2
Totale 5.228
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.851
IT - Italia 662
RU - Federazione Russa 382
SG - Singapore 369
CN - Cina 236
BR - Brasile 228
DE - Germania 159
HK - Hong Kong 119
VN - Vietnam 116
PL - Polonia 75
FI - Finlandia 64
BD - Bangladesh 56
FR - Francia 56
GB - Regno Unito 47
JP - Giappone 38
NL - Olanda 37
CA - Canada 35
IN - India 26
AR - Argentina 22
AT - Austria 21
IE - Irlanda 21
KR - Corea 15
MX - Messico 15
CH - Svizzera 13
IQ - Iraq 12
SE - Svezia 11
TW - Taiwan 11
TR - Turchia 10
UA - Ucraina 10
UZ - Uzbekistan 10
BE - Belgio 9
MY - Malesia 8
EG - Egitto 7
ZA - Sudafrica 7
EC - Ecuador 6
ID - Indonesia 6
KE - Kenya 6
RO - Romania 6
VE - Venezuela 6
JM - Giamaica 5
PK - Pakistan 5
TN - Tunisia 5
CO - Colombia 4
CR - Costa Rica 4
DK - Danimarca 4
DZ - Algeria 4
PH - Filippine 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
BO - Bolivia 3
CL - Cile 3
EE - Estonia 3
GT - Guatemala 3
IR - Iran 3
NP - Nepal 3
PA - Panama 3
SV - El Salvador 3
TH - Thailandia 3
BG - Bulgaria 2
CG - Congo 2
CI - Costa d'Avorio 2
ES - Italia 2
GH - Ghana 2
HN - Honduras 2
IL - Israele 2
MA - Marocco 2
NZ - Nuova Zelanda 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KN - Saint Kitts e Nevis 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
VI - Stati Uniti Isole Vergini 1
Totale 4.909
Salva come PNG Salva come JPEG
Città #
Ashburn 262
San Jose 261
Palermo 233
Singapore 233
Chandler 99
Hong Kong 90
Council Bluffs 73
Zgierz 71
Fairfield 62
Moscow 59
Helsinki 56
Beijing 55
Chicago 55
Los Angeles 51
The Dalles 47
Milan 41
Hefei 35
Hanoi 34
Santa Clara 34
Dallas 32
Lauterbourg 31
New York 31
Tokyo 31
Ho Chi Minh City 30
Cambridge 29
Woodbridge 27
Rome 25
Ann Arbor 24
Ludwigshafen am Rhein 24
Houston 21
Medford 20
Wilmington 20
São Paulo 19
Berlin 18
Central 18
Frankfurt am Main 17
Dublin 16
Nuremberg 16
San Diego 16
Toronto 16
Buffalo 15
Princeton 15
Orem 14
Altamura 13
Lawrence 13
London 13
Vienna 13
Boston 10
Brussels 9
Columbus 9
Naples 9
San Francisco 9
Seattle 9
Tampa 9
Lappeenranta 8
Lercara Friddi 8
Tashkent 8
West Jordan 8
Amsterdam 7
Belo Horizonte 7
Des Moines 7
Philadelphia 7
Salt Lake City 7
San Paolo di Civitate 7
Andover 6
Atlanta 6
Boardman 6
Da Nang 6
Lugano 6
Nairobi 6
Nashville 6
North Bergen 6
Padova 6
Paris 6
Partanna 6
Rio de Janeiro 6
Taipei 6
Turin 6
Bengaluru 5
Cagliari 5
Cairo 5
Campinas 5
Capaci 5
Catania 5
Catanzaro 5
Corigliano Calabro 5
Curitiba 5
Haiphong 5
Hanover 5
Manchester 5
Mexico City 5
Napoli 5
Redondo Beach 5
Stockholm 5
Tianjin 5
Washington 5
Ankara 4
Baghdad 4
Brooklyn 4
Buenos Aires 4
Totale 2.756
Salva come PNG Salva come JPEG
Nome #
Current development of CFTR potentiators in the last decade 288
[1,2]OXAZOLE DERIVATIVES: SYNTHESIS AND BIOLOGICAL EVALUATION AGAINST MULTIPLE MALIGNANT CELL TYPES 239
Insight on [1,3]thiazolo[4,5-e]isoindoles as tubulin polymerization inhibitors 205
Citrus wastewater as a source of value‐added products: Quali‐quantitative analysis and in vitro screening on breast cancer cell lines 197
Evaluation of [1,2]oxazolo[5,4-e]isoindoles in lymphoma cells 188
Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis 186
GPCR Inhibition in Treating Lymphoma 185
Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes 175
Pyrrolo[2',3':3,4]cyclohepta[1,2-d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types 170
Exploring the anticancer activity and the mechanism of action of pyrrolomycins F obtained by microwave-assisted total synthesis 168
Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein 161
An overview on anti-tubulin agents for the treatment of lymphoma patients 152
Editorial: Emerging heterocycles as bioactive compounds 151
THE KEY ROLE OF THE CLINICAL PHARMACIST IN THE MANAGEMENT OF ANTICANCER THERAPIES: A PILOT STUDY IN THE TREATMENT OF PATIENTS WITH NON-SMALL CELL LUNG CANCER 150
Insight on pyrimido[5,4-g]indolizine and pyrimido[4,5-c]pyrrolo[1,2-a]azepine systems as promising photosensitizers on malignant cells 145
Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel 145
Identification of 6,9-dihydro-5H-pyrrolo[3,2-h]quinazolines as a new class of F508del-CFTR correctors for the treatment of cystic fibrosis 140
Transcriptome and computational analysis assess the anti-tubulin activity of [1,2]oxazole derivatives in lymphoma 139
Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors 137
Modulators of anion channels and transporters as alternative therapeutic agents to normalize airway surface liquid in cystic fibrosis 131
Recurrence of the oxazole motif in tubulin colchicine site inhibitors with anti-tumor activity 129
Novel insights on [1,2]oxazolo[5,4‐e]isoindoles on multidrug resistant acute myeloid leukemia cell line 123
A Tetrahydro-isoquinoline derivative as a novel mGlu2/3 Ago/PAM with therapeutic potential in models of Parkinsonism 119
Identification of pyrrolo[3′,4’:3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas 116
Screening of fractions from marine sponges and other invertebrates to identify new lead compounds with anti-tumor activity in lymphoma models 116
Secondary resistance to the PI3K inhibitor copanlisib in marginal zone lymphoma 112
HSV-1 Glycoprotein D and Its Surface Receptors: Evaluation of Protein–Protein Interaction and Targeting by Triazole-Based Compounds through In Silico Approaches 111
In silico-guided exploration of SIRT6 modulation: Discovery of new fragments hits inhibitors 111
Advances in developing noncovalent small molecules targeting Keap1 110
New tricyclic systems as photosensitizers towards triple negative breast cancer cells 108
Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas 107
Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences 104
Synthesis of 2H-Imidazo[2′,1':2,3] [1,3]thiazolo[4,5-e]isoindol-8-yl-phenylureas with promising therapeutic features for the treatment of acute myeloid leukemia (AML) with FLT3/ITD mutations 102
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 85
Microwave‐Enhanced Synthesis of 2‐Styrylquinoline‐4‐Carboxamides With Promising Anti‐Lymphoma Activity 84
The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib 63
Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma 62
In Silico-Guided Design, Synthesis and In Vitro Evaluation of Thiazolo-pyridines Targeting SARS-CoV-2 Nsp13 8
Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction 3
A critical analysis on ENaC inhibitors, unravelling molecular medicinal insights and promising research roadmap in the treatment of cystic fibrosis 3
Totale 5.228
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.595
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022218 0 0 0 6 5 14 16 9 63 33 15 57
2022/2023542 34 60 18 29 64 61 29 43 64 51 72 17
2023/2024346 15 32 14 46 22 29 75 36 10 12 19 36
2024/2025997 47 66 52 75 38 62 162 87 49 98 121 140
2025/20262.334 170 54 204 217 186 339 304 231 213 133 145 138
2026/2027523 110 68 311 34 0 0 0 0 0 0 0 0
Totale 5.228